After the end of every calendar quarter, the Navellier research team tests for "what is working on Wall Street" to develop fundamental variable models that we think are good predictors of stock movements. A key variable included in virtually every model our firm has ever produced is known as "earnings surprise." An earnings surprise occurs whenever a company's actual earnings report either exceeds (positive) or fails (negative) to meet analysts' earnings expectations. Since we don't short stocks, we look for positive earnings surprises. The academic research is conclusive about earnings surprises: there is a statistically significant correlation between a company's surprise earnings announcement and an increase in the company's stock price: click the following link and type in ‘earnings surprise’ Earnings Surprise.
We think our portfolios are packed with companies reporting compelling earnings surprises. Below are the complete holdings of six of our portfolio strategies showing earnings surprises. (Where you see “#N/A,” the companies likely either (1) lacked sufficient analyst estimates to generate an earnings surprise value or (2) were reporting no surprises).
This data is updated on Tuesdays as of 2pm Pacific Time.
|Ticker||Company Name||Price||Last Actual
|LW||Lamb Weston Holdings Inc||71.11||04/02/2019||$0.83||$0.95||14.69%|
|LULU||Lululemon Athletica Inc||169.88||03/28/2019||$1.74||$1.85||6.17%|
|BURL||Burlington Stores Inc||158.43||03/07/2019||$2.77||$2.83||2.20%|
|ROST||Ross Stores Inc||97.37||03/06/2019||$1.13||$1.20||6.39%|
|VEEV||Veeva Systems Inc||134.75||02/27/2019||$0.40||$0.45||11.84%|
|KEYS||Keysight Technologies Inc||91.84||02/22/2019||$0.80||$0.93||15.98%|
|CDNS||Cadence Design Systems Inc||64.98||02/20/2019||$0.47||$0.52||10.05%|
|VRSK||Verisk Analytics Inc||136.98||02/20/2019||$1.07||$1.04||-2.64%|
|ANET||Arista Networks Inc||324.77||02/15/2019||$2.06||$2.25||8.98%|
|CME||Cme Group Inc||172.92||02/14/2019||$1.73||$1.77||2.05%|
|ORLY||O'reilly Automotive Inc||406.32||02/07/2019||$3.75||$3.72||-0.85%|
|SPGI||S&p Global Inc||214.93||02/07/2019||$2.20||$2.22||0.76%|
|NBIX||Neurocrine Biosciences Inc||86.24||02/06/2019||$0.18||$0.19||4.01%|
|IDXX||Idexx Labs Inc||225.32||02/01/2019||$0.90||$0.99||9.59%|
|PYPL||Paypal Holdings Inc||108.48||01/31/2019||$0.67||$0.69||3.59%|
|ISRG||Intuitive Surgical Inc||582.85||01/25/2019||$3.07||$2.96||-3.54%|
|GWW||Grainger (w W) Inc||304.86||01/24/2019||$3.60||$3.96||10.08%|
|TEAM||Atlassian Corp Plc||112.68||01/18/2019||$0.21||$0.25||19.05%|
|UNH||Unitedhealth Group Inc||223.22||01/15/2019||$3.21||$3.28||2.21%|
Although the information in this communication is believed to be materially correct, no representation or warranty, express or implied, is given as to the accuracy of any of the information provided. Certain information included in this communication is based on information obtained from sources considered to be reliable. However, any projections or analysis provided to assist the recipient of this communication in evaluating the matters described herein may be based on subjective assessments and assumptions and may use one among alternative methodologies that produce different results. Accordingly, any projections or analysis should not be viewed as factual and should not be relied upon as an accurate prediction of future results. Furthermore, to the extent permitted by law, neither Navellier & Associates, Inc. (“Navellier”), nor any of its affiliates, agents, or service providers assumes any liability or responsibility nor owes any duty of care for any consequences of any person acting or refraining to act in reliance on the information contained in this communication or for any decision based on it. This communication is not intended to constitute, and should not be construed as, investment advice. Potential investors in any Navellier investment products should seek their own independent financial advice. Navellier does not provide investment advice. This communication has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any Navellier investment strategy or composites. This communication is not intended as and is not to be taken as an offer or solicitation with respect to the purchase or sale of any security or interest, nor does it constitute an offer or solicitation in any jurisdiction, including those in which such an offer or solicitation is not authorised or to any person to whom it is unlawful to make such a solicitation or offer.
Potential investors should consult with their financial advisor before investing in any Navellier Investment Product.
It should not be assumed that any securities recommendations made by Navellier & Associates, Inc., in the future will be profitable or equal the performance of securities made in this report.
Investment in equity strategies is speculative in nature and involves substantial risk, including the potential for partial or complete loss of funds invested.
Navellier claims compliance with Global Investment Performance Standards (GIPS). To receive a complete list and descriptions of Navellier's composites and/or a presentation that adheres to the GIPS standards, please contact Navellier or click here. It should not be assumed that any securities recommendations made by Navellier & Associates, Inc. in the future will be profitable or equal the performance of securities made in this report. Request here a list of recommendations made by Navellier & Associates, Inc. for the preceding twelve months.